Trial Profile
A multi-institutional registry study to evaluate the effect of concomitant capecitabine with hepatic delivery of drug eluting beads in metastatic colorectal cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- 10 Dec 2015 New trial record